Walpar Nutritions Limited (NSE:WALPAR)
26.10
0.00 (0.00%)
At close: Oct 13, 2026
Walpar Nutritions Revenue
In the fiscal year ending March 31, 2026, Walpar Nutritions had annual revenue of 789.14M INR with 9.66% growth. Walpar Nutritions had revenue of 422.93M in the half year ending March 31, 2026, with 34.09% growth. That makes Walpar Nutritions the 38,148th largest company in the world by revenue and 3,396th in India.
Revenue
789.14M
Revenue Growth
+9.66%
P/S Ratio
0.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
245.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 789.14M | 69.54M | 9.66% |
| Mar 31, 2025 | 719.60M | 93.47M | 14.93% |
| Mar 31, 2024 | 626.13M | 272.57M | 77.10% |
| Mar 31, 2023 | 353.55M | 85.81M | 32.05% |
| Mar 31, 2022 | 267.74M | 85.69M | 47.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Rajnish Wellness | 1.68B |
| JFL Life Sciences | 1.31B |
| Deccan Health Care | 818.34M |
| Sandu Pharmaceuticals | 696.24M |
| Panjon | 492.78M |
| Gujarat Terce Laboratories | 456.22M |